Acute kidney injury: Difference between revisions
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
#Loss - Complete loss of kidney function for >4wk | #Loss - Complete loss of kidney function for >4wk | ||
#ESRD - Need for renal replacement therapy for >3mo | #ESRD - Need for renal replacement therapy for >3mo | ||
===Chronic Kidney Disease Stages=== | |||
*Useful if pt's baseline creatinine is unknown | |||
**Stage 1: Kidney damage (e.g. proteinuria) and normal GFR; GFR >90 | |||
**Stage 2: Kidney damage (e.g. proteinuria) and mild decr in GFR; GFR 60-89 | |||
**Stage 3: Moderate decrease in GFR; GFR >30-59 | |||
**Stage 4: Severe decrease in GFR; GFR 15-29 | |||
**Stage 5: Kidney failure (dialysis or kidney transplant needed); GFR <15 | |||
==Risk Factors== | ==Risk Factors== | ||
| Line 18: | Line 25: | ||
#Hepatorenal syndrome | #Hepatorenal syndrome | ||
#Radiocontrast agents | #Radiocontrast agents | ||
==Etiology== | ==Etiology== | ||
# | ===Prerenal=== | ||
#Hypovolemia | |||
##GI: decreased intake, vomiting and diarrhea | |||
##Pharmacologic: diuretics | |||
##Third spacing | |||
###Pancreatitis | |||
##Skin losses: fever, burns | |||
##Miscellaneous | |||
###Hypoaldosteronism | |||
###Salt-losing nephropathy | |||
###Postobstructive diuresis | |||
#Hypotension | |||
##Septic vasodilation | |||
##Hemorrhage | |||
##Decreased cardiac output | |||
###Ischemia/infarction | |||
###Valvulopathy | |||
##Pharmacologic | |||
###B-blockers | |||
###CCBs | |||
###Antihypertensive medications | |||
##High-output failure | |||
###Thyrotoxicosis | |||
###AV fistula | |||
#Renal artery and small-vessel disease | |||
##Embolism: thrombotic, septic, cholesterol | |||
##Thrombosis: atherosclerosis, vasculitis, sickle cell disease | |||
##Dissection | |||
##Pharmacologic | |||
###NSAIDs | |||
###ACEI/ARB | |||
####Observed shortly after initiation of therapy | |||
##Microvascular thrombosis | |||
###Preeclampsia | |||
###HUS | |||
###DIC | |||
###vasculitis | |||
###SCD | |||
##Hypercalcemia | |||
===Intrinsic=== | |||
#Tubular diseases | |||
##Ischemic acute tubular necrosis | |||
###Caused by more advanced disease due to the prerenal causes | |||
#Nephrotoxins | |||
##Aminoglycosides, radiocontrast, amphotericin, heme pigments (rhabdo, hemolysis) | |||
##Obstruction | |||
###Uric acid, calcium oxalate, myeloma, amyloid | |||
###Pharmacologic: sulfonamide, triamterene, acyclovir, indinavir | |||
#Interstitial diseases | |||
##Acute interstitial nephritis: typically a drug reaction (NSAIDs, abx, phenytoin) | |||
##Infection: bilateral pyelonephritis, Legionnaire disease, hantavirus | |||
##Infiltrative disease: sarcoidosis, lymphoma | |||
##Autoimmune diseases: SLE | |||
#Glomerular diseases | |||
##Rapidly progressive glomerulonephritis | |||
###Goodpasture, Wegener granulomatosis, HSP, SLE, membranoproliferative GN | |||
##Postinfectious glomerulonephritis | |||
#Small-vessel diseases | |||
##Microvascular thrombosis | |||
###Preeclampsia, HUS, DIC, TTP, vasculitis (PAN, SCD, atheroembolism) | |||
##Malignant hypertension | |||
##Scleroderma | |||
##Renal vein thrombosis | |||
##FeNa <>1% | |||
##FeUN >50% | |||
## | ===Postrenal=== | ||
## | *Loss of renal function occurs over course of 10-14d in setting of complete obstruction | ||
## | **Risk of permanent renal failure increases significantly if complicated by UTI | ||
# | ====Etiology==== | ||
#Infants and children | |||
##Urethra and bladder outlet | |||
###Anatomic malformations | |||
####Urethral atresia | |||
####Meatal stenosis | |||
####Anterior and posterior urethral valves | |||
##Ureter | |||
###Anatomic malformations | |||
####Vesicoureteral reflux (female preponderance) | |||
####Ureterovesical junction obstruction | |||
####Ureterocele | |||
####Retroperitoneal tumor | |||
#All ages | |||
##Various locations in GU tract | |||
###Trauma | |||
###Blood clot | |||
##Urethra and bladder outlet | |||
###Phimosis or urethral stricture (male preponderance) | |||
###Neurogenic bladder | |||
####DM, spinal cord disease, multiple sclerosis, Parkinson's | |||
####Pharmacologic: anticholinergics, a-adrenergic antagonists, opiates | |||
#Adults | |||
##Urethra and bladder outlet | |||
###BPH | |||
###Cancer of prostate, bladder, cervix, or colon | |||
###Obstructed catheters | |||
##Ureter | |||
###Calculi, uric acid crystals | |||
###Papillary necrosis | |||
####SCD, DM, pyelonephritis | |||
###Tumor: Ureter, uterus, prostate, bladder, colon, rectum; retroperitoneal lymphoma | |||
###Retroperitoneal fibrosis: idiopathic, tuberculosis, sarcoidosis, propranolol | |||
###Stricture: TB, radiation, schistosomiasis, NSAIDs | |||
###Miscellaneous | |||
####Aortic aneurysm | |||
####Pregnant uterus | |||
####IBD | |||
####Trauma | |||
| Line 71: | Line 165: | ||
***Anuria | ***Anuria | ||
==Diagnosis== | |||
#Prerenal | |||
##BUN/Cr ratio > 20 | |||
##FeNa <1% ((urine sodium/plasma sodium) / (urine creatinine / serum creatinine)) | |||
##Urine osm >500 | |||
##Microscopic analysis | |||
###Hyaline casts | |||
#Instrinsic | |||
##FeNa >1% | |||
##Urine Osm <350 | |||
##Microscopic analysis | |||
###Acute glomerulonephritis: RBCs, casts | |||
###Acute tubular necrosis: protein, tubular epithelial cells | |||
#Postrenal | |||
##FeNa >1% | |||
##Urine Osm <350 | |||
==Work-up== | |||
#Urine | |||
##UA, urine sodium, urine creatinine, urine urea | |||
#ECG (hyperkalemia) | |||
#Imaging | |||
##CXR | |||
###Evidence of volume overload, PNA | |||
##US | |||
###Test of choice in setting of acute renal failure | |||
####Bladder size (post-void) | |||
####Hydronephrosis | |||
####IVC collapsibility (prerenal) | |||
##CT | |||
###Indicated if hydronephrois found on US in order to define the location of obstruction | |||
==Treatment== | |||
#Treat underlying cause | |||
== | #IVF (prerenal) | ||
# | #Obstruction | ||
# | ##Note: Postobstructive diuresis can result in significant volume loss and death | ||
# | ###Typically occurs when obstruction has been prolonged / has resulted in renal failure | ||
###Admit pts w/ persistent diuresis of >250 mL/h for >2hr | |||
##Foley | |||
##Suprapubic (if foley fails) | |||
#Dialysis | |||
##Indicated for: | |||
###A: Acidosis (severe) | |||
###E: Electrolyte abnormality (e.g. uncontrolled hyperkalemia) | |||
###I: Intoxicants (Lithium, ASA, methanol, ethylene glycol, theophylline) | |||
###O: Overload (volume) w/ persistent hypoxia | |||
###U: Uremic pericarditis/encephalopathy/bleeding dyscrasia | |||
###Also: | |||
####Na <115 or >165 mEq/L | |||
####BUN >100 | |||
==Disposition== | ==Disposition== | ||
Revision as of 23:11, 3 August 2011
Background
- Majority of cases of community-acquired ARF is secondary to volume depletion
RIFLE Classification
- Risk - Serum Cr increased 1.5x baseline
- Injury - Serum Cr increased 2.0x baseline
- Failure - Serum Cr increased 3.0x baseline OR Cr >4 and acute increase >0.5
- Loss - Complete loss of kidney function for >4wk
- ESRD - Need for renal replacement therapy for >3mo
Chronic Kidney Disease Stages
- Useful if pt's baseline creatinine is unknown
- Stage 1: Kidney damage (e.g. proteinuria) and normal GFR; GFR >90
- Stage 2: Kidney damage (e.g. proteinuria) and mild decr in GFR; GFR 60-89
- Stage 3: Moderate decrease in GFR; GFR >30-59
- Stage 4: Severe decrease in GFR; GFR 15-29
- Stage 5: Kidney failure (dialysis or kidney transplant needed); GFR <15
Risk Factors
- Atherosclerosis
- Chronic hypertension
- Chronic kidney disease
- NSAIDs
- ACEI/ARB
- Sepsis
- Hypercalcemia
- Hepatorenal syndrome
- Radiocontrast agents
Etiology
Prerenal
- Hypovolemia
- GI: decreased intake, vomiting and diarrhea
- Pharmacologic: diuretics
- Third spacing
- Pancreatitis
- Skin losses: fever, burns
- Miscellaneous
- Hypoaldosteronism
- Salt-losing nephropathy
- Postobstructive diuresis
- Hypotension
- Septic vasodilation
- Hemorrhage
- Decreased cardiac output
- Ischemia/infarction
- Valvulopathy
- Pharmacologic
- B-blockers
- CCBs
- Antihypertensive medications
- High-output failure
- Thyrotoxicosis
- AV fistula
- Renal artery and small-vessel disease
- Embolism: thrombotic, septic, cholesterol
- Thrombosis: atherosclerosis, vasculitis, sickle cell disease
- Dissection
- Pharmacologic
- NSAIDs
- ACEI/ARB
- Observed shortly after initiation of therapy
- Microvascular thrombosis
- Preeclampsia
- HUS
- DIC
- vasculitis
- SCD
- Hypercalcemia
Intrinsic
- Tubular diseases
- Ischemic acute tubular necrosis
- Caused by more advanced disease due to the prerenal causes
- Ischemic acute tubular necrosis
- Nephrotoxins
- Aminoglycosides, radiocontrast, amphotericin, heme pigments (rhabdo, hemolysis)
- Obstruction
- Uric acid, calcium oxalate, myeloma, amyloid
- Pharmacologic: sulfonamide, triamterene, acyclovir, indinavir
- Interstitial diseases
- Acute interstitial nephritis: typically a drug reaction (NSAIDs, abx, phenytoin)
- Infection: bilateral pyelonephritis, Legionnaire disease, hantavirus
- Infiltrative disease: sarcoidosis, lymphoma
- Autoimmune diseases: SLE
- Glomerular diseases
- Rapidly progressive glomerulonephritis
- Goodpasture, Wegener granulomatosis, HSP, SLE, membranoproliferative GN
- Postinfectious glomerulonephritis
- Rapidly progressive glomerulonephritis
- Small-vessel diseases
- Microvascular thrombosis
- Preeclampsia, HUS, DIC, TTP, vasculitis (PAN, SCD, atheroembolism)
- Malignant hypertension
- Scleroderma
- Renal vein thrombosis
- Microvascular thrombosis
- FeNa <>1%
- FeUN >50%
Postrenal
- Loss of renal function occurs over course of 10-14d in setting of complete obstruction
- Risk of permanent renal failure increases significantly if complicated by UTI
Etiology
- Infants and children
- Urethra and bladder outlet
- Anatomic malformations
- Urethral atresia
- Meatal stenosis
- Anterior and posterior urethral valves
- Anatomic malformations
- Ureter
- Anatomic malformations
- Vesicoureteral reflux (female preponderance)
- Ureterovesical junction obstruction
- Ureterocele
- Retroperitoneal tumor
- Anatomic malformations
- Urethra and bladder outlet
- All ages
- Various locations in GU tract
- Trauma
- Blood clot
- Urethra and bladder outlet
- Phimosis or urethral stricture (male preponderance)
- Neurogenic bladder
- DM, spinal cord disease, multiple sclerosis, Parkinson's
- Pharmacologic: anticholinergics, a-adrenergic antagonists, opiates
- Various locations in GU tract
- Adults
- Urethra and bladder outlet
- BPH
- Cancer of prostate, bladder, cervix, or colon
- Obstructed catheters
- Ureter
- Calculi, uric acid crystals
- Papillary necrosis
- SCD, DM, pyelonephritis
- Tumor: Ureter, uterus, prostate, bladder, colon, rectum; retroperitoneal lymphoma
- Retroperitoneal fibrosis: idiopathic, tuberculosis, sarcoidosis, propranolol
- Stricture: TB, radiation, schistosomiasis, NSAIDs
- Miscellaneous
- Aortic aneurysm
- Pregnant uterus
- IBD
- Trauma
- Urethra and bladder outlet
Clinical Features
- Acute renal failure itself has few symptoms until severe uremia develops:
- N/V, drowsiness, fatigue, confusion, coma
- Pts more likely to present w/ symptoms related to underlying cause:
- Prerenal
- Thirst, orthostatic light-headedness, decreasing urine output
- Intrinsic
- Flank pain, hematuria
- Nephrolithiasis
- Papillary necrosis
- Crystal-induced nephropathy
- Myalgias, seizures, recreational intoxication
- Pigment-induced ARF (rhabdo)
- Darkening urine and edema (esp w/ preceding pharyngitis or cutaneous infection)
- Acute glomerulonephritis
- Fever, arthralgia, rash
- Acute interstitial nephritis
- Cough, dyspnea, hemoptysis
- Goodpasture, Wegener granulomatosis
- Flank pain, hematuria
- Postrenal
- Alternating oliguria and polyuria is pathognomonic of obstruction
- Anuria
- Prerenal
Diagnosis
- Prerenal
- BUN/Cr ratio > 20
- FeNa <1% ((urine sodium/plasma sodium) / (urine creatinine / serum creatinine))
- Urine osm >500
- Microscopic analysis
- Hyaline casts
- Instrinsic
- FeNa >1%
- Urine Osm <350
- Microscopic analysis
- Acute glomerulonephritis: RBCs, casts
- Acute tubular necrosis: protein, tubular epithelial cells
- Postrenal
- FeNa >1%
- Urine Osm <350
Work-up
- Urine
- UA, urine sodium, urine creatinine, urine urea
- ECG (hyperkalemia)
- Imaging
- CXR
- Evidence of volume overload, PNA
- US
- Test of choice in setting of acute renal failure
- Bladder size (post-void)
- Hydronephrosis
- IVC collapsibility (prerenal)
- Test of choice in setting of acute renal failure
- CT
- Indicated if hydronephrois found on US in order to define the location of obstruction
- CXR
Treatment
- Treat underlying cause
- IVF (prerenal)
- Obstruction
- Note: Postobstructive diuresis can result in significant volume loss and death
- Typically occurs when obstruction has been prolonged / has resulted in renal failure
- Admit pts w/ persistent diuresis of >250 mL/h for >2hr
- Foley
- Suprapubic (if foley fails)
- Note: Postobstructive diuresis can result in significant volume loss and death
- Dialysis
- Indicated for:
- A: Acidosis (severe)
- E: Electrolyte abnormality (e.g. uncontrolled hyperkalemia)
- I: Intoxicants (Lithium, ASA, methanol, ethylene glycol, theophylline)
- O: Overload (volume) w/ persistent hypoxia
- U: Uremic pericarditis/encephalopathy/bleeding dyscrasia
- Also:
- Na <115 or >165 mEq/L
- BUN >100
- Indicated for:
Disposition
Admit
See Also
Source
Tintinalli
